Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AXIS 2: AX200 for the Treatment of Ischemic Stroke - A Multinational, Multicenter, Randomized, Doubleblind, Placebo-controlled Phase II Trial

NCT00927836 is registered in ClinicalTrials.gov with Sygnis Bioscience GmbH & Co KG as lead sponsor.

NCT NCT00927836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00927836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AXIS 2: AX200 for the Treatment of Ischemic Stroke - A Multinational, Multicenter, Randomized, Doubleblind, Placebo-controlled Phase II Trial
Lead sponsor
Sygnis Bioscience GmbH & Co KG
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2009
Completion date
November 30, 2011
Enrollment
328 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke